Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1204) 1204
humans (1130) 1130
antigenemia (796) 796
male (643) 643
female (636) 636
adult (551) 551
middle aged (464) 464
cytomegalovirus (424) 424
transplantation (394) 394
infection (390) 390
immunology (366) 366
cytomegalovirus infections - diagnosis (323) 323
infectious diseases (311) 311
disease (305) 305
adolescent (297) 297
cytomegalovirus - isolation & purification (284) 284
diagnosis (243) 243
microbiology (242) 242
aged (230) 230
recipients (227) 227
virology (226) 226
cytomegalovirus - genetics (217) 217
pp65 antigenemia (213) 213
polymerase chain reaction (209) 209
ganciclovir (203) 203
hematology (202) 202
antigens, viral - blood (197) 197
cytomegalovirus - immunology (197) 197
cytomegalovirus infections - virology (196) 196
risk factors (190) 190
child (183) 183
antiviral agents - therapeutic use (180) 180
sensitivity and specificity (178) 178
viral load (168) 168
viremia (168) 168
blood (162) 162
retrospective studies (156) 156
dna, viral - blood (155) 155
dna (153) 153
prospective studies (152) 152
infections (151) 151
polymerase-chain-reaction (151) 151
health aspects (150) 150
antigenemia assay (147) 147
cytomegalovirus infections (146) 146
cytomegalovirus infections - prevention & control (141) 141
animals (138) 138
cytomegalovirus infections - drug therapy (138) 138
ganciclovir - therapeutic use (138) 138
virus diseases (138) 138
child, preschool (129) 129
polymerase chain reaction - methods (126) 126
surgery (124) 124
polymerase chain-reaction (123) 123
aids/hiv (121) 121
cytomegalovirus infections - immunology (121) 121
therapy (121) 121
cytomegalovirus infections - etiology (120) 120
oncology (118) 118
young adult (116) 116
preemptive therapy (115) 115
cmv (114) 114
viral matrix proteins - blood (111) 111
phosphoproteins - blood (108) 108
aids (104) 104
prevention (103) 103
transplantation, homologous (103) 103
hematopoietic stem cell transplantation - adverse effects (102) 102
bone-marrow-transplantation (99) 99
peripheral-blood leukocytes (98) 98
treatment outcome (98) 98
infant (97) 97
risk-factors (96) 96
cytomegalovirus infections - blood (93) 93
real-time pcr (91) 91
children (89) 89
abridged index medicus (88) 88
mortality (87) 87
prophylaxis (87) 87
research (87) 87
prevalence (86) 86
virus (86) 86
pcr (85) 85
time factors (85) 85
cytomegalovirus infections - complications (84) 84
stem-cell transplantation (84) 84
hematopoietic stem cell transplantation (83) 83
hiv (80) 80
antigens (79) 79
immunocompromised host (79) 79
incidence (79) 79
cmv infection (78) 78
human cytomegalovirus (78) 78
medicine, general & internal (76) 76
kidney transplantation (74) 74
predictive value of tests (74) 74
cytomegalovirus infections - epidemiology (73) 73
follow-up studies (73) 73
stem cells (72) 72
virus infection (72) 72
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1434) 1434
Spanish (44) 44
French (39) 39
Japanese (12) 12
Portuguese (9) 9
Korean (6) 6
Turkish (5) 5
Polish (3) 3
Chinese (2) 2
German (2) 2
Czech (1) 1
Persian (1) 1
Russian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy
by Domènech, Eugeni and Vega, Roser and Ojanguren, Isabel and Hernández, Águeda and Garcia-Planella, Esther and Bernal, Isabel and Rosinach, Mercè and Boix, Jaume and Cabré, Eduard and Gassull, Miquel A
Inflammatory Bowel Diseases, ISSN 1078-0998, 2008, Volume 14, Issue 10, pp. 1373 - 1379
Background: Cytomegalovirus (CMV) infection has been reported in ulcerative colitis (UC). especially in severe, steroid-refractory disease. However, its role... 
Pp67 mRNA | Antigenemia | Cytomegalovirus | Immunomodulators | Ulcerative colitis | CMV ANTIGENEMIA | antigenemia | pp67 mRNA | RENAL-ALLOGRAFT RECIPIENTS | VIRUS | INFLAMMATORY-BOWEL-DISEASE | REQUIRING COLONIC RESECTION | THERAPY | cytomegalovirus | immunomodulators | ulcerative colitis | STEM-CELL TRANSPLANTATION | GASTROENTEROLOGY & HEPATOLOGY | CLINICAL-SIGNIFICANCE | ANTIGENEMIA ASSAY | BLOOD | Immunohistochemistry | Prevalence | Prospective Studies | Colitis, Ulcerative - virology | Cytomegalovirus Infections - epidemiology | Humans | Middle Aged | Male | Antibodies, Viral - blood | Colitis, Ulcerative - epidemiology | Case-Control Studies | Young Adult | Aged, 80 and over | Adult | Female | Steroids - therapeutic use | Colitis, Ulcerative - drug therapy | Drug Resistance | Severity of Illness Index | Cytomegalovirus - isolation & purification | Diagnosis, Differential | Comorbidity | Cytomegalovirus Infections - diagnosis | Cyclosporine - therapeutic use | Cytomegalovirus - immunology | Colitis, Ulcerative - diagnosis | Aged | Index Medicus | Inflammatory bowel diseases | Intravenous administration | Cyclosporins | Antibodies | azathioprine | mRNA | Infection | Biopsy | Intestine | Inclusion bodies | Rectum | Steroid hormones
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text How I treat cytomegalovirus in hematopoietic cell transplant recipients
by Boeckh, Michael and Ljungman, Per
Blood, ISSN 0006-4971, 2009, Volume 113, Issue 23, pp. 5711 - 5719
Cytomegalovirus (CMV) continues to cause major complications after hematopoietic cell transplantation (HCT). Over the past decade, most centers have adopted... 
SERONEGATIVE BLOOD PRODUCTS | ALLOGENEIC BONE-MARROW | POLYMERASE-CHAIN-REACTION | RISK-FACTORS | INTRAVENOUS IMMUNE GLOBULIN | DOUBLE-BLIND | PREEMPTIVE THERAPY | PP65 ANTIGENEMIA | PRIMARY CMV INFECTION | HEMATOLOGY | VERSUS-HOST-DISEASE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
by Rajasingham, Radha, Dr and Smith, Rachel M, MD and Park, Benjamin J, MD and Jarvis, Joseph N, MRCP and Govender, Nelesh P, MMed and Chiller, Tom M, MD and Denning, David W, Prof and Loyse, Angela, MD [Res] and Boulware, David R, MD
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 8, pp. 873 - 881
Summary Background Cryptococcus is the most common cause of meningitis in adults living with HIV in sub-Saharan Africa. Global burden estimates are crucial to... 
Infectious Disease | INFECTIOUS DISEASES | INITIATION | LONG-TERM OUTCOMES | ADULTS | OPPORTUNISTIC INFECTIONS | AIDS | ANTIRETROVIRAL THERAPY | COHORT | EARLY MORTALITY | CARE | ANTIGENEMIA | Anti-Retroviral Agents - therapeutic use | Lost to Follow-Up | Prevalence | Global Health | Humans | Middle Aged | Male | CD4 Lymphocyte Count | Incidence | Meningitis, Cryptococcal - mortality | Young Adult | Antigens, Fungal - blood | Global Burden of Disease | Meningitis, Cryptococcal - epidemiology | Treatment Failure | Adolescent | HIV Infections - complications | Survival Analysis | Aged, 80 and over | Adult | Female | HIV Infections - drug therapy | Aged | Highly active antiretroviral therapy | Medical research | Cryptococcal meningitis | Analysis | Medicine, Experimental | Disease susceptibility | HIV (Viruses) | Antiretroviral drugs | Mortality | Income | Health risks | Infections | Estimates | Antiretroviral therapy | CD4 antigen | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Cryptococcus | Meningitis | Fatalities | Adults | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Neonatal Cytomegalovirus Blood Load and Risk of Sequelae in Symptomatic and Asymptomatic Congenitally Infected Newborns
by Lanari, Marcello and Lazzarotto, Tiziana and Venturi, Valentina and Papa, Irene and Gabrielli, Liliana and Guerra, Brunella and Landini, Maria Paola and Faldella, Giacomo
Pediatrics, ISSN 0031-4005, 01/2006, Volume 117, Issue 1, pp. e76 - e83
OBJECTIVE. Human cytomegalovirus (CMV) is a ubiquitous human-specific DNA virus and is the main cause of congenital virus infection in developed countries... 
Prognostic value | Cytomegalovirus | DNAemia | Sensorineural hearing loss | Neurodevelopmental defects | pp65 antigenemia | Sequelae | sensorineural hearing loss | antigenemia | MANAGEMENT | FOLLOW-UP | MONOCLONAL-ANTIBODY | pp65 | MATERNAL INFECTION | CHILDREN | sequelae | HEARING-LOSS | POLYMERASE-CHAIN-REACTION | LEUKOCYTES | cytomegalovirus | prognostic value | PREDICTORS | neurodevelopmental defects | PEDIATRICS | PRENATAL-DIAGNOSIS | Cytomegalovirus - isolation & purification | Developmental Disabilities - etiology | Humans | Risk Factors | Infant | Male | Cytomegalovirus Infections - complications | Cytomegalovirus Infections - diagnosis | Viral Load | Central Nervous System Diseases - etiology | Hearing Loss, Sensorineural - etiology | Female | Child Development | Cytomegalovirus Infections - congenital | Infant, Newborn | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Model of population pharmacokinetics of cidofovir in immunocompromised children with cytomegalovirus and adenovirus infection
by Neant, Nadege and Klifa, Roman and Bouazza, Naim and Moshous, Despina and Neven, Benedicte and Leruez-Ville, Marianne and Blanche, Stephane and Treluyer, Jean-Marc and Hirt, Deborah and Frange, Pierre
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2018, Volume 73, Issue 9, pp. 2422 - 2429
Objectives: To describe cidofovir pharmacokinetics and assess the link between concentration and safety/efficacy in children. Patients and methods: An... 
CELL TRANSPLANT RECIPIENTS | INFECTIOUS DISEASES | VIREMIA | THERAPY | VIRUS | MECHANISM | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | BRINCIDOFOVIR | ANTIGENEMIA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Urine Antigen Detection as an Aid to Diagnose Invasive Aspergillosis
by Marr, Kieren A and Datta, Kausik and Mehta, Seema and Ostrander, Darin B and Rock, Michelle and Francis, Jesse and Feldmesser, Marta
Clinical Infectious Diseases, ISSN 1058-4838, 11/2018, Volume 67, Issue 11, pp. 1705 - 1711
An immunodiagnostic assay that detects Aspergillus galactofuranose-containing antigens in urine was developed in dipstick format. Performance evaluated in a... 
galactofuranose | diagnostics | galactomannan | urine | aspergillosis | INFECTIOUS DISEASES | CIRCULATING GALACTOMANNAN | REACTIVITY | MICROBIOLOGY | IMMUNOLOGY | FUNGAL-INFECTIONS | ORGANIZATION | GALACTOMANNAN ANTIGENEMIA | BIOSYNTHESIS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Lower gamma globulin level before conditioning is a risk factor for cytomegalovirus antigenemia after pediatric allogeneic stem cell transplantation
by Kobayashi, Ryoji and Hori, Daiki and Matsushima, Satoru and Sano, Hirozumi and Suzuki, Daisuke and Kobayashi, Kunihiko
Pediatric Blood & Cancer, ISSN 1545-5009, 04/2019, Volume 66, Issue 4, pp. e27586 - n/a
Background Despite the development of early detection methods and new antiviral drugs, cytomegalovirus (CMV) infection remains a persistent and sometimes... 
CMV antigenemia | gamma globulin | CMV | risk factor | ASSAY | BONE-MARROW-TRANSPLANTATION | PREVENTION | CMV-ASSOCIATED DISEASE | ONCOLOGY | DNA | PEDIATRICS | INFECTION | HEMATOLOGY | RAPID DIAGNOSIS | PCR | BLOOD | Antiviral agents | Pediatrics | Medical research | Stem cells | Medicine, Experimental | Cytomegalovirus infections | Transplantation | Children | Health aspects | Risk factors | Gamma globulin | Cytomegalovirus | Stem cell transplantation | Infections | Multivariate analysis | Drug development | Risk analysis | Patients | Immunosuppressive agents | Globulins | Antigenemia | Preconditioning
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study
by Kredel, Lea I and Mundt, Pamela and van Riesen, Linda and Jöhrens, Korinna and Hofmann, Jörg and Loddenkemper, Christoph and Siegmund, Britta and Preiß, Jan C
International Journal of Colorectal Disease, ISSN 0179-1958, 2/2019, Volume 34, Issue 2, pp. 229 - 237
The optimal method for detecting CMV colitis in patients with inflammatory bowel disease (IBD) has not been established. We wanted to investigate which... 
Inflammatory bowel diseases | Medicine & Public Health | Surgery | Hepatology | Gastroenterology | Internal Medicine | Cytomegalovirus colitis | Diagnostic algorithm | Proctology | Ulcerative colitis | Crohn’s disease | SURGERY | ANTIVIRAL THERAPY | LOAD | ULCERATIVE-COLITIS | BIOPSY | Crohn's disease | PREVALENCE | RISK-FACTOR | REACTIVATION | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | PCR | ANTIGENEMIA ASSAY | Immunohistochemistry | Splenomegaly | Cytomegalovirus | Patients | Immunosuppressive agents | Inflammatory bowel disease | Leukocytosis | Intestine | Cerebral blood flow | Peripheral blood | Pp65 protein | Antigenemia | Colon | Colitis | Immunofluorescence | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Prévalence de l'antigénémie cryptococcique et les facteurs associés chez les patients infectés par le VIH à Cotonou au Bénin
by Ogouyèmi-Hounto, A and Zannou, D.M and Ayihounton, G and Ahouada, C and Azon-Kouanou, A and Acakpo, J and Sissinto Savi de Tove, Y and Kinde Gazard, D
Journal de Mycologie Medicale, ISSN 1156-5233, 12/2016, Volume 26, Issue 4, pp. 391 - 397
Objective Determine the prevalence of cryptococcal antigenemia and associated factors in HIV-infected patients in Cotonou in order to introduce systematic... 
Prevention | Benin | Screening | HIV | Cryptococcal antigenemia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Validation of clinic-based cryptococcal antigen lateral flow assay screening in HIV-infected adults in South Africa
by Drain, PK and Hong, T and Krows, M and Govere, S and Thulare, H and Wallis, CL and Gosnell, BI and Moosa, MY and Bassett, IV and Celum, C
SCIENTIFIC REPORTS, ISSN 2045-2322, 02/2019, Volume 9, Issue 1, pp. 2687 - 8
Since rapid cryptococcal antigen lateral flow assays (CrAg LFA) may expedite treatment of HIV-associated cryptococcal infections, we sought to validate... 
MENINGITIS | ANTIRETROVIRAL THERAPY | SERUM | MULTIDISCIPLINARY SCIENCES | Urine | Antigens | Human immunodeficiency virus--HIV | Antigenemia | Meningitis | Enzyme immunoassay | Blood | CD4 antigen
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Screening for anal cancer precursors: what is the learning curve for high-resolution anoscopy?
by Smith, S and Mounzer, K
AIDS, ISSN 0269-9370, 06/2014, Volume 28, Issue 9, pp. 1375 - 1376
INFECTIOUS DISEASES | VIROLOGY | B SURFACE ANTIGENEMIA | BLOOD-DONORS | IMMUNOLOGY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Detection of acute toxoplasmosis: The genitally transmittable infection
by Shojaee, Saeedeh and Keshavarz, Hossien
International Journal of Women's Health and Reproduction Sciences, 2014, Volume 2, Issue 2, pp. 91 - 93
Toxoplasma | Antigenemia | PCR
Journal Article
Details down arrow
13. Full Text Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: Evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients
by Elmaagacli, Ahmet H and Steckel, Nina K and Koldehoff, Michael and Hegerfeldt, Yael and Trenschel, Rudolf and Ditschkowski, Markus and Christoph, Sandra and Gromke, Tanja and Kordelas, Lambros and Ottinger, Hellmut D and Ross, Rudolf S and Horn, Peter A and Schnittger, Susanne and Beelen, Dietrich W
Blood, ISSN 0006-4971, 08/2011, Volume 118, Issue 5, pp. 1402 - 1412
The impact of early human cytomegalovirus (HCMV) replication on leukemic recurrence was evaluated in 266 consecutive adult (median age, 47 years; range, 18-73... 
REDUCED RISK | BONE-MARROW-TRANSPLANTATION | HOST-DISEASE | PREEMPTIVE THERAPY | PP65 ANTIGENEMIA | CMV INFECTION | STEM-CELL TRANSPLANTATION | RECIPIENTS | HEMATOLOGY | T-CELLS | SIBLING DONORS | Recurrence | Graft vs Leukemia Effect - physiology | Down-Regulation | Humans | Middle Aged | Risk Factors | Hematopoietic Stem Cell Transplantation | Male | Cytomegalovirus Infections - complications | Leukemia, Myeloid, Acute - virology | Leukemia, Myeloid, Acute - complications | Transplantation, Homologous | Young Adult | Time Factors | Adolescent | Adult | Female | Aged | Cytomegalovirus - physiology | Virus Replication - physiology | Leukemia, Myeloid, Acute - therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Construction and evaluation of cytomagalovirus DNA quantification system with real-time detection polymerase chain reaction
by Hatayama, Yuki and Hashimoto, Yuki and Hara, Ayako and Motokura, Toru
Yonago Acta Medica, ISSN 0513-5710, 09/2016, Volume 59, Issue 3, pp. 217 - 222
Cytomegalovirus | CMV antigenemia | Quantification | RTD-PCR
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text A randomized controlled trial of plasma real-time PCR and antigenemia assay for monitoring CMV infection after unrelated BMT
by Kanda, Y and Yamashita, T and Mori, T and Ito, T and Tajika, K and Mori, S and Sakura, T and Hara, M and Mitani, K and Kurokawa, M and Akashi, K and Harada, M
Bone Marrow Transplantation, ISSN 0268-3369, 08/2010, Volume 45, Issue 8, pp. 1325 - 1332
Preemptive therapy is the standard strategy for preventing CMV disease after allogeneic hematopoietic SCT. In this study, unrelated BMT recipients were... 
preemptive therapy | antigenemia | real-time PCR | CMV | ALLOGENEIC MARROW TRANSPLANTATION | GANCICLOVIR PROPHYLAXIS | PP65 ANTIGENEMIA | HUMAN CYTOMEGALOVIRUS ANTIGENEMIA | IMMUNOLOGY | RECIPIENTS | TRANSPLANTATION | POLYMERASE-CHAIN-REACTION | ONCOLOGY | DISEASE | DNAEMIA CUTOFF | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Premedication - methods | Humans | Middle Aged | Male | Cytomegalovirus Infections - diagnosis | Transplantation, Homologous | Polymerase Chain Reaction - methods | Young Adult | Antigens, Viral - blood | Bone Marrow Transplantation - immunology | Cytomegalovirus Infections - prevention & control | Drug Dosage Calculations | Virus Activation - drug effects | Bone Marrow Transplantation - adverse effects | Cytomegalovirus Infections - etiology | Adult | Colitis - drug therapy | Ganciclovir - administration & dosage | Prevention | Polymerase chain reaction | Complications and side effects | Ganciclovir | Bone marrow | Cytomegalovirus infections | Dosage and administration | Transplantation | Biological assay | Risk factors | Methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Severe gastrointestinal cytomegalovirus disease in two patients with renal vasculitis after immunosuppression
by Lee, Kian-Guan and Teo, Su-Hooi and Lim, Cynthia Ciwei and Loh, Alwin Hwai-Liang and Chidambaram, Viswanath Anand and Choo, Jason Chon Jun
Clinical Nephrology, ISSN 0301-0430, 2016, Volume 86, Issue 3, pp. 154 - 161
Although the use of current immunosuppressive regimens has significantly improved the outcomes of autoimmune renal diseases, infectious complications remain an... 
ANCA vasculitis | Cytomegalovirus | Gastrointestinal CMV | CMV ANTIGENEMIA | SYSTEMIC-LUPUS-ERYTHEMATOSUS | RISK-FACTORS | TRANSPLANTATION | THERAPY | cytomegalovirus | AUTOIMMUNE-DISEASES | RITUXIMAB | gastrointestinal CMV | UROLOGY & NEPHROLOGY | INFECTION | RHEUMATIC-DISEASES | ANTIGENEMIA ASSAY | Immunosuppression - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Vasculitis - drug therapy | Gastrointestinal Diseases - etiology | Cytomegalovirus Infections - etiology | Kidney Diseases - drug therapy | Female | Immunosuppressive Agents - adverse effects | Male | Gastrointestinal Diseases - virology
Journal Article
Details down arrow
17. Full Text Characteristic endoscopic findings and risk factors for cytomegalovirus-associated colitis in patients with active ulcerative colitis
by Yutaka Hirayama;Takafumi Ando;Yoshiki Hirooka;Osamu Watanabe;Ryoji Miyahara;Masanao Nakamura;Takeshi Yamamura;Hidemi Goto
世界胃肠内镜杂志：英文版（电子版）, ISSN 1948-5190, 2016, Volume 8, Issue 6, pp. 301 - 309
AIM: To identify characteristic endoscopic findings and risk factors for cytomegalovirus (CMV)-associated colitis in patients with active ulcerative colitis... 
Cytomegalovirus | Risk | colitis;Antigenemia | factor | Ulcerative | Colonoscopy | Antigenemia | Risk factor | Retrospective Study | Ulcerative colitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
by Marty, Francisco M, Dr and Ljungman, Per, Prof and Papanicolaou, Genovefa A, MD and Winston, Drew J, MD and Chemaly, Roy F, MD and Strasfeld, Lynne, MD and Young, Jo-Anne H, MD and Rodriguez, Tulio, MD and Maertens, Johan, Prof and Schmitt, Michael, MD and Einsele, Hermann, Prof and Ferrant, Augustin, MD and Lipton, Jeffrey H, MD and Villano, Stephen A, MD and Chen, Hongzi, PhD and Boeckh, Michael, Prof and Maribavir 1263-300 Clinical Study and Maribavir 1263-300 Clinical Study Group
Lancet Infectious Diseases, The, ISSN 1473-3099, 2011, Volume 11, Issue 4, pp. 284 - 292
Summary Background Available drugs against cytomegalovirus have adverse effects that compromise their prophylactic use in recipients of allogeneic stem-cell... 
Infectious Disease | VALACYCLOVIR | INFECTIOUS DISEASES | MULTICENTER | POLYMERASE-CHAIN-REACTION | BONE-MARROW-TRANSPLANTATION | GANCICLOVIR PROPHYLAXIS | REACTIVATION | PREEMPTIVE THERAPY | PP65 ANTIGENEMIA | INFECTION | STRATEGIES | United States | Humans | Middle Aged | Male | Transplantation | Stem Cell Transplantation | Young Adult | Cytomegalovirus Infections - prevention & control | Benzimidazoles - administration & dosage | Ribonucleosides - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Placebos - administration & dosage | Double-Blind Method | Administration, Oral | Europe | Treatment Outcome | Antiviral Agents - administration & dosage | Canada | Antiviral Agents - adverse effects | Adolescent | Aged | Ribonucleosides - adverse effects | Chemoprevention - methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights